Join Discovery Life Sciences during CB&CDx Boston 2024 at Booth #27
Join our Speaking Engagement on Day 2, Sep 5 at 12:50pm
Presented by: Staci J Kearney, PhD, RAC, Founder & Chief Executive Officer at Elevation Strategic Development LLC
Title: The Nuances of Biomarker Implementation in a Clinical Trial: A Regulatory Perspective
- Define the intended use of a clinical trial assay (CTA) versus a CDx-ready assay
- Compare implementation of biomarker strategy in US and EU
- Understand implications of study design on regulatory requirements US v EU
Schedule a Meeting at CB&CDx